DANA BROCCOLI was a philanthropist, novelist, producer, actress, and creative muse. She collaborated with her husband, ALBERT ROMOLO “CUBBY” BROCCOLI, on the production of more than 15 films. The couple launched the James Bond series, the most successful film franchise in Hollywood history. In recognition of that achievement, Mr. Broccoli received the Irving G. Thalberg Award from the Academy of Motion Picture Arts and Sciences, the Order of the British Empire from Queen Elizabeth II, and the title Commandeur des Arts et des Lettres from the French government. With his death, Mrs. Broccoli became the custodian of the James Bond franchise and, as such, she was lauded for her contributions by the Ian Fleming Foundation. Dana Broccoli died in 2004.
With her children, Barbara Broccoli and Michael Wilson, Mrs. Broccoli founded the DANA AND ALBERT R. BROCCOLI CHARITABLE FOUNDATION to support the arts, children’s services, medicine, and higher education. At Johns Hopkins, the foundation has established the Dana and Albert “Cubby” Broccoli Center for Aortic Diseases and supported the Walter J. Stark Distinguished Professorship in Ophthalmology. In addition, the Broccoli family has donated the proceeds from the East Coast premieres of three James Bond films to Hopkins and the Broccoli Center for Aortic Diseases. In 2001, the foundation established the Dana and Albert “Cubby” Broccoli Professorship in Oncology to advance discovery in breast cancer and vaccine therapies at the Sidney Kimmel Comprehensive Cancer Center.
Held by Elizabeth M. Jaffee
ELIZABETH M. JAFFEE, M.D.. is an internationally recognized expert in cancer immunology and pancreatic cancer. She is Deputy Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Co-Director of the Skip Viragh Pancreatic Cancer Center and Associate Director of the Bloomberg Kimmel Institute for Cancer Immunotherapy. Her research focus is on developing novel immunotherapies for the treatment and prevention of pancreatic cancer. Her recent work has focused on developing novel biomarker driven immunotherapy clinical trials to dissect the complex inflammatory signals within the tumor microenvironment. Through collaborations with computational biologists, her team has identified a number of immune suppressive signals that regulate pancreatic cancer development and progression.
Dr. Jaffee is a Past President of AACR. She has served on a number of committees at the National Cancer Institute, including the co-chair of the Biden Moonshot Blue Ribbon Panel which identified high impact research priorities for the NCI. She currently serves as Chief Medical Advisor to the Lustgarten Foundation for Pancreatic Cancer Research. She is the inaugural director of the Convergence Institute for Integrating Technologies and Computational Sciences at Johns Hopkins. Dr. Jaffee is a member of the National Academy of Medicine, a Fellow of the American College of Physicians, a Fellow of American Association for the Advancement of Science, a Fellow of the SITC Academy of Immuno-Oncology and a Fellow of the AACR Academy. Most recently, she was appointed chair of President Biden’s Cancer Panel.